USA Change Macroaxis User Registration

Home Portfolios Solutions About Us

More ROI Blog

Company Contact UsPress ReleasesTerms Of UseAdvertisingWays To Invest

US Market Closed: Feb 8, 03:40 AM 2012

NYSE 8069.71 NASDAQ 2904.08

and more..

sponsered by

Processing
Collecting necessary data for SLXP and PBH...

Asset Comparison and Correlation

View All Portfolios

More Actions
- Select Assests
- Optimize Portfolio
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatilities
- Import Equities
- Search Equities
- Filter Tops

Salix Pharmaceuticals Ltd. and

Prestige Brand Holdings Inc.

Volatility

Matrix

Run Correlation

Diversification

Good diversification

Overlapping area represents amount of risk that can be diversified away by holding Salix Pharmaceuticals Ltd. and Prestige Brand Holdings Inc. in the same portfolio (assuming nothing else is changed)

Optimize

Correlation Coefficient

-0.11

Parameters

Time Period	1 Month [change]
Direction	Negative
Strength	Insignificant
Accuracy	92.0%
Values	Daily Returns

Suggest

Salix Pharmaceuticals Ltd.

Profile

48.43

Intraday

One Month

^0.00

0.00%

SLXP

NASDAQ

Salix Pharmaceuticals Ltd.

P/E	37.25	Low	Not Applicable
P/B Ratio	5.96	Market Cap	2.864B
Sector	Healthcare	Last Close	48.43
Short Ratio	7.80	Last Traded	2/7/2012
Year High	50.28	Change (%)	Not Applicable
EBITDA	142.7M	Year Low	25.64
Book Value	8.127	EPS	1.30
PEG Ratio	0.94	Employees	390
Target Price	54.27	Current EPS	1.30
This Year EPS	2.53	Next Year EPS	2.78
Current PE	37.25	This Year PE	19.14
Next Year PE	17.42	Dividend	Not Applicable

Prestige Brand Holdings Inc. C

Profile

13.4

Intraday

One Month

^0.00

0.00%

PBH

NYSE

Prestige Brand Holdings Inc.

P/E	18.56	Low	Not Applicable
P/B Ratio	1.72	Market Cap	673.4M
Sector	Healthcare	Last Close	13.40
Short Ratio	7.10	Last Traded	2/7/2012
Year High	13.62	Change (%)	Not Applicable
EBITDA	113.8M	Year Low	8.15
Book Value	7.79	EPS	0.722
PEG Ratio	1.27	Employees	100
Target Price	15.67	Current EPS	0.722
This Year EPS	0.96	Next Year EPS	1.15
Current PE	18.56	This Year PE	13.96
Next Year PE	11.65	Dividend	Not Applicable